Week ending 24 July 

International data

Below is the latest international comparison of Covid-19 data using WHO published figures. As mentioned before, country to country comparison has some limitations because of the variation in approach, data collection and testing.

 

Data from 23/07/2020:

 

  • Worldwide, there are 15,012,731 confirmed cases (an increase of 12.2% and 1,631,078 more cases) and 619,150 deaths (an increase of 6.7% and 39,089 more deaths) than last week. This suggests that worldwide cases and deaths may be rising slightly faster as the change last week was 11.3% and 5,6% respectively.
  • The number of UK cases accounts for 2.0% of world cases at 296,381 and 7.3% of world deaths due to coronavirus (45,501 deaths). The UK continues to be ranked at 9 in terms of number of cases and remains the country with the highest death toll in Europe and third highest in the world.
  • The USA remains the country with the most cases and deaths in the world, accounting for 25.8% of world cases (3,868,453 cases) and 22.9% of total deaths (141,479 deaths).
  • Latin America continues to be a hotspot of the pandemic as cases and deaths continue to rise. Brazil continues to be the worst hit with the second highest death toll in the world with 81,487 deaths, an increase of 10% since last week.
  • South Africa continues to see an increase in cases, where cases have increased by 27% in the past week to 394,948 ranking them at 5 (83,899 more cases since last week). South Africa also has the largest percentage increase in deaths where there has been a 33% increase to 5,940 deaths in the past week (1,487 more deaths).
  • Cases rising in Pakistan indicate that it could become the next hotspot in Asia as cases rise by 11,277 to 269,191 (4% more cases).
  • Currently, England has 14 times more cases than Scotland (18,500 cases), 15 times more cases than Wales (17,030 cases) and 44 times more cases than Northern Ireland (5,876 cases) (PHE data).

 

   

Cases

Deaths

Death rate

1

USA

                         3,868,453

                            141,479

3.7%

2

Brazil

                         2,159,654

                              81,487

3.8%

3

India

                         1,238,635

                              29,861

2.4%

4

Russia

                            795,038

                              12,892

1.6%

5

South Africa

                            394,948

                                5,940

1.5%

6

Peru

                            362,087

                              13,579

3.8%

7

Mexico

                            356,255

                              40,400

11.3%

8

Chile

                            336,402

                                8,722

2.6%

9

UK

                            296,381

                              45,501

15.4%

10

Iran

                            281,413

                              14,853

5.3%

11

Pakistan

                            269,191

                                5,709

2.1%

 

 

 

International policy updates

 

Global

 

 

Europe

 

  • Belgium’s health minister has announced that there will be no easing of restrictions at the beginning of August, as was previously planned. She added that local measures could also be applied in places that have experienced new outbreaks.
  • France gives 7 million citizens free COVID-19 face masks, amid concerns that the financial burden of basic protective equipment is out of reach for those living in poverty.

 

Africa

 

 

North America

 

 

South America

 

 

Middle East

 

 

Asia

 

 

Australia

 

 

 

International spotlight on… the vaccine race

 

According to a statement published by the Business Secretary, Alok Sharma, there will be an additional “£100 million to ensure that any successful COVID-19 vaccine can be produced at scale in the U.K.”. In practice that means a new Cell and Gene Therapy Catapult Manufacturing Innovation Centre.

 

Following a $2bn deal with Pfizer Inc and German biotech BioNTech SE, the US has set a benchmark for COVID-19 vaccine pricing. The deal secures enough vaccines to inoculate 50 million Americans for about $40 per person (or the price of an annual flu shot). This is part of the U.S government’s Operation Warp Speed programme, which seeks to nurture a government-industry partnership. The UK has also signed a deal to secure 30 million doses of this vaccine (which injects part of the coronavirus’ genetic code).

 

There are currently more than 165 vaccines against coronavirus in development, 27 of which are in the human trial stage. Three of those are in the Phase III stage, and most recently a vaccine developed by the University of Oxford appears safe and triggers an immune response. The UK has ordered 100 million doses of this vaccine.

 

The key is to ensure that any vaccine that is proven to be substantially effective can be administered at scale across the country, and the world. Gavi, the vaccine alliance, is co-leading a global effort to ensure that any response to COVID-19 is effective and fair, primarily by identifying and rapidly accelerating development, production and delivery of COVID-19 vaccines so that anyone that needs them, gets them. At the end of April, the WHO developed the Access to Covid-19 Tools (ACT) accelerator, this is a framework for collaboration (not a decision-making body) that aims to support the development and equitable distribution of the diagnostics, vaccines and treatments the world needs. 14 countries and the European Commission have so far committed to the accelerator, and the Economist Intelligence Unit have developed a COVID-19 Health Funding tracker to independently track pledges, allocations, disbursements of funding for the global health response to COVID-19, as a way to provide an independent record of which funders are funding which aspects of the global health response. The tracker will help increase accountability and target further pledges towards critical funding gaps.